Profound Medical (NASDAQ:PROF) just reported results for the first quarter of 2024.
- Profound Medical reported earnings per share of -26 cents. This was above the analyst estimate for EPS of -30 cents.
- The company reported revenue of $1.91 million.
- This was 24.21% worse than the analyst estimate for revenue of $2.52 million.